Enjoy complimentary customisation on priority with our Enterprise License!
The arrhythmia monitoring devices market share is expected to increase by USD 2.79 billion from 2021 to 2025, and the market's growth momentum will accelerate at a CAGR of 8%.
This arrhythmia monitoring devices market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by product (ECG and Holter monitors, implantable cardiac monitors, and cardiac event monitors) and geography (North America, Europe, ROW, and Asia). The arrhythmia monitoring devices market report also offers information on several market vendors, including Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., BIOTRONIK SE & Co. KG, B-Secur Ltd., CardioComm Solutions Inc., General Electric Co., Hillrom, Koninklijke Philips NV, and Medtronic Plc, among others.
Download the Free Report Sample to Unlock the Arrhythmia Monitoring Devices Market Size for the Forecast Period and Other Important Statistics
Based on our research output, there has been a positive impact on the market growth during and post the COVID-19 era. The growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases is notably driving the arrhythmia monitoring devices market growth, although factors such as high costs associated with arrhythmia monitoring devices may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the arrhythmia monitoring devices market industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Arrhythmia Monitoring Devices Market Driver
The growing number of cardiac cases related to the irregularity in heart rhythms and structural heart diseases is boosting the demand for arrhythmia monitoring devices. Ventricular fibrillation leads the heart's lower chamber to stop beating and pumping blood to the body. This can lead to arrhythmia, causing cardiac arrest. With the increasing number of structural heart diseases and the irregularity in heart rhythms and other conditions, there is a growing demand for arrhythmia monitoring devices.
Key Arrhythmia Monitoring Devices Market Challenge
The high cost of arrhythmia monitoring devices and procedures can affect the adoption of arrhythmia monitoring devices. Moreover, few countries provide reimbursement for arrhythmia procedures, which has negatively affected market growth. In developing countries such as India and China, there is no government reimbursement for such procedures. Patients must depend on private insurance companies. The average cost of arrhythmia monitoring devices differs based on product types. Thus, high arrhythmia monitoring procedure cost and limited or no reimbursement has led patients to opt for other substitutes such as pulse oximeters, thereby affecting the growth of the market.
This arrhythmia monitoring devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the arrhythmia monitoring devices market encompasses successful business strategies deployed by the key vendors. The arrhythmia monitoring devices market is fragmented, and the vendors are deploying growth strategies such as mergers and acquisitions to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The arrhythmia monitoring devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
32% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for arrhythmia monitoring devices in North America. Market growth in this region will be faster than the growth of the market in ROW.
Manufacturers in North America are increasing the adoption of their products through awareness programs and marketing strategies, which, in turn, will facilitate the arrhythmia monitoring devices market's growth in North America during the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The arrhythmia monitoring devices market share growth by the ECG and Holter monitors segment will be significant during the forecast period. The growing involvement of companies and universities in studying and developing products in the segment will expand the product portfolio, thereby propelling market growth.
This report provides an accurate prediction of the contribution of all the segments to the growth of the arrhythmia monitoring devices market size and actionable market insights on the post-COVID-19 impact on each segment.
Arrhythmia Monitoring Devices Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8% |
Market growth 2021-2025 |
USD 2.79 billion |
Market structure |
Fragmented |
YoY growth (%) |
6.93 |
Regional analysis |
North America, Europe, ROW, and Asia |
Performing market contribution |
North America at 32% |
Key consumer countries |
The US, Germany, France, Japan, and Canada |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., BIOTRONIK SE & Co. KG, B-Secur Ltd., CardioComm Solutions Inc., General Electric Co., Hillrom, Koninklijke Philips NV, and Medtronic Plc |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.